{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:06:50Z","timestamp":1764259610361},"reference-count":85,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,10,22]],"date-time":"2007-10-22T00:00:00Z","timestamp":1193011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Cellular Biochemistry"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bone metastasis is often the penultimate harbinger of death for many cancer patients. Bone metastases are often associated with fractures and severe pain resulting in decreased quality of life. Accordingly, effective therapies to inhibit the development or progression of bone metastases will have important clinical benefits. To achieve this goal understanding the mechanisms through which bone metastases develop and progress may provide targets to inhibit the metastases. In the past few years, there have been advances in both understanding the mechanisms through which bone metastases develop and how they impact bone remodeling. Additionally, gains in promising clinical strategies to target bone metastases have been developed. In this prospectus, we will discuss some of these advances. J. Cell. Biochem. 102: 1095\u20131102, 2007. \u00a9 2007 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jcb.21540","type":"journal-article","created":{"date-parts":[[2007,10,22]],"date-time":"2007-10-22T14:22:12Z","timestamp":1193062932000},"page":"1095-1102","source":"Crossref","is-referenced-by-count":15,"title":["New trends in the treatment of bone metastasis"],"prefix":"10.1002","volume":"102","author":[{"given":"Evan T.","family":"Keller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Escara\u2010Wilke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Ignatoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell S.","family":"Taichman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,10,22]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"831","article-title":"Androgen receptor negatively influences the expression of chemokine receptors (CXCR4, CCR1) and ligand\u2010mediated migration in prostate cancer DU\u2010145","volume":"16","author":"Akashi T","year":"2006","journal-title":"Oncol Rep"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400892"},{"key":"e_1_2_8_4_1","first-page":"178","article-title":"Bisphosphonates in multiple myeloma","volume":"47","author":"Apperley JF","year":"1999","journal-title":"Pathol Biol (Paris)"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.4.640"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(01)00404-5"},{"key":"e_1_2_8_7_1","first-page":"2949","article-title":"Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases","volume":"60","author":"Boissier S","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)01122-5"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.2008"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1991.tb15260.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-0266(00)00065-6"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8 <1588::AID-CNCR9>3.0.CO;2-G"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02966406"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.030031"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3534"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood.V93.5.1697","article-title":"Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease","volume":"93","author":"Dallas SL","year":"1999","journal-title":"Blood"},{"key":"e_1_2_8_17_1","first-page":"693","article-title":"Preliminary evidence that oral clodronate delays symptomatic progression of bone metastases from prostate cancer: First results of the MRC Pr05 Trial","volume":"20","author":"Dearnaley D","year":"2001","journal-title":"Proc Am Soc Clin Oncol Annual Meeting"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600925"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12 <3080::AID-CNCR27>3.0.CO;2-W"},{"key":"e_1_2_8_20_1","first-page":"627","article-title":"Monoclonal antibody targeting RANKL as a therapy for cancer\u2010induced bone diseases","volume":"16","author":"Dougall W","year":"2006","journal-title":"Clin Calcium"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-006-9021-3"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.18.2412"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0688"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199710000-00007"},{"issue":"1","key":"e_1_2_8_25_1","first-page":"65","article-title":"Mechanisms of action of the bisphosphonates","volume":"57","author":"Fleisch H","year":"1997","journal-title":"Medicina (B Aires)"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.20.11756"},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00003086-198609000-00005","article-title":"Skeletal metastases","volume":"210","author":"Galasko CS","year":"1986","journal-title":"Clin Orthop Relat Res"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650090211"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01682343"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1287"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-200101000-00033"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300609200"},{"key":"e_1_2_8_33_1","first-page":"1619","article-title":"Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells","volume":"62","author":"Holen I","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/74999"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043452640"},{"key":"e_1_2_8_36_1","article-title":"Osteoprotegrin and the bone homing and colonization potential of breast cancer cells","author":"Kapoor P","year":"2007","journal-title":"J Cell Biochem"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/16852"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.82B1.9483"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81569-X"},{"key":"e_1_2_8_40_1","article-title":"RANKL\u2010dependent and RANKL\u2010independent mechanisms of macrophage\u2010osteoclast differentiation in breast cancer","author":"Lau YS","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0031"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12 <3033::AID-CNCR20>3.0.CO;2-C"},{"key":"e_1_2_8_43_1","first-page":"4038","article-title":"Osteoprotegerin diminishes advanced bone cancer pain","volume":"61","author":"Luger NM","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<263::AID-IJC19>3.0.CO;2-T"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<6::AID-CNCR3>3.0.CO;2-D"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.558"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502023320506"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0540"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.8697"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.2741\/2290"},{"key":"e_1_2_8_51_1","first-page":"4432","article-title":"Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis","volume":"61","author":"Morony S","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000240885.64568.9e"},{"key":"e_1_2_8_53_1","first-page":"125","article-title":"Prostate cancer in the late 1990s: Hormone refractory disease options","volume":"19","author":"Moul JW","year":"1999","journal-title":"Urol Nurs"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/35065016"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.8.12.2009"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.3.509"},{"key":"e_1_2_8_57_1","first-page":"2572","article-title":"Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB\u2010IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy","volume":"61","author":"Oyajobi BO","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_8_58_1","first-page":"571","article-title":"The distribution of secondary growth in cancer of the breast","volume":"1","author":"Paget S","year":"1829","journal-title":"Lancet"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12 <3047::AID-CNCR22>3.0.CO;2-U"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.201394498"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(97)00289-5"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2006.037853"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2006.09.018"},{"key":"e_1_2_8_64_1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-5347(17)66278-5","article-title":"Calcium studies in ten cases of osteoblastic prostatic metastasis","volume":"79","author":"Roland S","year":"1958","journal-title":"J Urol"},{"key":"e_1_2_8_65_1","first-page":"308","article-title":"Advances in bone biology: The osteoclast","volume":"17","author":"Roodman GD","year":"1996","journal-title":"Endocrine Rev"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-999-0112-7"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2442"},{"key":"e_1_2_8_68_1","first-page":"5294","article-title":"The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway","volume":"58","author":"Shipman CM","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809059253"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02310.x"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80209-3"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006513413583"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006524610591"},{"key":"e_1_2_8_74_1","first-page":"699","article-title":"Radiation\u2010induced apoptosis: Predictive and therapeutic significance in radiotherapy of prostate cancer (review)","volume":"7","author":"Szostak MJ","year":"2000","journal-title":"Oncol Rep"},{"key":"e_1_2_8_75_1","first-page":"1832","article-title":"Use of the stromal cell\u2010derived factor\u20101\/CXCR4 pathway in prostate cancer metastasis to bone","volume":"62","author":"Taichman RS","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(00)00087-4"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00824-X"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.10.7037"},{"key":"e_1_2_8_79_1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/bip.20653","article-title":"Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents","volume":"88","author":"Tsutsumi H","year":"2007","journal-title":"Biopolymers"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.139.3.5837"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.3597"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119435"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12 <2979::AID-CNCR13>3.0.CO;2-U"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11685"},{"key":"e_1_2_8_85_1","first-page":"7883","article-title":"Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone","volume":"63","author":"Zhang J","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_8_86_1","first-page":"48","article-title":"The role of the liver environment in the regulation of colon cancer metastasis","volume":"2","author":"Zvibel I","year":"2000","journal-title":"Isr Med Assoc J"}],"container-title":["Journal of Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcb.21540","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcb.21540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T04:32:07Z","timestamp":1697171527000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcb.21540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,22]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1002\/jcb.21540"],"URL":"https:\/\/doi.org\/10.1002\/jcb.21540","archive":["Portico"],"relation":{},"ISSN":["0730-2312","1097-4644"],"issn-type":[{"value":"0730-2312","type":"print"},{"value":"1097-4644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,22]]}}}